首页> 美国卫生研究院文献>Cancer Medicine >A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators
【2h】

A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators

机译:一种基于低分化簇的新型组织学分级方案适用于治疗的直肠癌并与确定的组织病理学预后相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The conventional histologic grading of colorectal cancer (CRC) is less suited for resected rectal cancer following neoadjuvant chemoradiation. Enumeration of poorly differentiated clusters (PDC) is a recently proposed histologic grading scheme. We aimed to apply PDC grading to treated rectal cancer and to test the prognostic significance of this novel approach. Archived hematoxylin and eosin slides of 72 rectal adenocarcinomas resected following neoadjuvant treatment were retrieved. PDC, tumor budding, and tumor regression were assessed. The parameters were correlated with clinicopathological features and survival. PDC was strongly associated with tumor budding, perineural invasion (PNI), metastasis, and low degree of tumor regression. Tumor budding was significantly associated with lymphovascular invasion and PNI, and metastasis. Tumors with a lower degree of regression were more likely to show high pathologic T stage and advanced clinical stage. Local recurrence was associated with poor survival. PDC did not correlate with overall survival. PDC grading is applicable to resected rectal cancer status post neoadjuvant treatment and correlates with established histopathological prognosticators. PDC and tumor budding may represent a histologic spectrum reflective of the same biological significance. Validation and incorporation of these simple histologic grading schemes may strengthen the prognostic power of the histologic parameters that influence the oncologic outcome in treated rectal cancer. Further study to evaluate the significance of PDC as an oncologic prognosticator is warranted.
机译:大肠癌(CRC)的常规组织学分级不太适合新辅助化学放疗后切除的直肠癌。枚举低分化簇(PDC)是最近提出的组织学分级方案。我们旨在将PDC分级应用于治疗的直肠癌,并测试这种新方法的预后意义。检索72例新辅助治疗后切除的直肠腺癌的苏木和曙红载玻片。评估PDC,肿瘤萌芽和肿瘤消退。这些参数与临床病理特征和生存率相关。 PDC与肿瘤发芽,神经周围浸润(PNI),转移和肿瘤消退程度低密切相关。肿瘤出芽与淋巴管浸润,PNI和转移密切相关。退化程度较低的肿瘤更有可能显示高病理T期和晚期临床期。局部复发与生存不良有关。 PDC与总体生存率无关。 PDC分级适用于新辅助治疗后切除的直肠癌状态,并与确定的组织病理学预后相关。 PDC和肿瘤出芽可能代表了反映相同生物学意义的组织学谱。这些简单的组织学分级方案的验证和纳入可能会增强影响治疗的直肠癌的肿瘤学结果的组织学参数的预后能力。有必要进行进一步的研究以评估PDC作为肿瘤预后的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号